LONDON, March 18, 2014 /PRNewswire/ --
On Monday, March 17, 2014, the US markets saw a positive sentiment with the NASDAQ Composite closing at 4,279.95, up 0.81%, the Dow Jones Industrial Average ending the session at 16,247.22, up 1.13% and the S&P 500 edging 0.96% higher to finish the trading session at 1,858.83. The gains were broad based as all the 10 sectors ended the session in positive. During the session healthy gains in the Information Technology, Industrials and Financial sectors positively impacted the broader market. A number of stocks saw large movements, including Celldex Therapeutics Inc. (NASDAQ: CLDX), Sonus Networks Inc. (NASDAQ: SONS), You On Demand Holdings Inc. (NASDAQ: YOD), and CombiMatrix Corporation (NASDAQ: CBMX), which were amongst the top gainers for the session. Free research on these four companies can be accessed at:
Celldex Therapeutics Inc.'s stock finished Monday's session at $24.18, recording a gain of 4.49%. A total of 2.73 million shares traded which is above the three months average volume of 2.13 million shares. The stock vacillated between $23.44 and $25.22 during the session. Shares in Celldex Therapeutics Inc. have gained 2.50% in the previous three months, while the same has fallen by 11.04% in the last one month and 0.12% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 0.91% during the trading session and charted up 9.89% in the previous three months. Additionally, the stock is trading at the RSI of 36.13 and above its 200-day moving average of $23.78. Sign up and read the free notes on CLDX at:
Sonus Networks Inc.'s stock edged 5.23% higher, finishing Monday's session at $3.62, with 4.76 million shares traded during the session as compared to a three months average volume of 1.52 million shares. The stock fluctuated between $3.55 and $3.78 during the trading session. Sonus Networks Inc.'s shares have advanced 14.20% in the last one month and 19.47% in the previous three months. The company's shares have gone up 14.92% on YTD basis. The S&P 500 Information Technology Sector Index mapped a gain of 1.32% during the trading session and charted up 5.34% in the previous three months. Furthermore, the stock is trading at the RSI of 44.52 and above its 50-day and 200-day moving averages of $3.28 and $3.25, respectively. The complimentary notes on SONS can be downloaded as in PDF format at:
On Monday, shares in You On Demand Holdings Inc. ended the day at $6.65, which is 29.13% higher than the previous day's closing price of $5.15. A total of 5.58 million shares were traded as compared to the three months average volume of 1.40 million shares. During the session, the stock oscillated between $5.07 and $6.70. The company's shares have rallied 35.16% in the previous three trading sessions and 15.65% in the last one month. You On Demand Holdings Inc.'s shares have gone up 194.25% on YTD basis. The S&P 500 Consumer Discretionary Sector Index mapped a gain of 0.71% during the trading session and charted up 2.55% in the previous three months. Furthermore, the stock is trading at the RSI of 53.48 and above its 50-day and 200-day moving averages of $3.99 and $2.41, respectively. Register for free on Investor-Edge and access the latest research on YOD at:
Shares in CombiMatrix Corp. closed Monday's session at $3.50, up 14.75% with a trading volume of 5.03 million shares as compared to a three months average volume of 0.89 million shares. The stock traded between $3.05 and $3.58 during the session. The company's shares have gone up 52.17% on YTD basis. CombiMatrix Corp.'s shares have surged 14.75% in the previous three trading sessions and 17.85% in the last one month. The S&P 500 Health Care Sector Index mapped a gain of 0.91% during the trading session and charted up 1.18% in the last one month. Moreover, the stock is trading at the RSI of 58.22 and above its 50-day and 200-day moving averages of $2.88 and $2.87, respectively. The complete research on CBMX is available for free at:
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.